MeSH Browser

MeSH Supplementary: bivatuzumab mertansine
Unique ID: C519271
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C519271
Entry Term(s): BIWI 1 compound
Pharm Action: Antineoplastic Agents, Immunological
Immunotoxins
Antineoplastic Agents, Phytogenic
Registry Number: 0
Previous Indexing: *ANTIGBODIES, MONOCLONAL (2007-2011)
Heading Mapped to: Maytansine / *analogs & derivatives; *Antibodies, Monoclonal, Humanized
Frequency: 3
Note: CD44v6-targeting humanized monoclonal antibody coupled to the toxin mertansine for treatment of squamous cell carcinoma of the head and neck
Source: Int J Oncol 2007 Apr;30(4):927-35
Date of Entry: 2007/05/02
Revision Date: 2017/09/22

bivatuzumab mertansine MeSH Supplementary Concept Data 2023